# Olanzapine in the Treatment of Anorexia Nervosa

> **NCT00592930** · PHASE4 · COMPLETED · sponsor: **Northwell Health** · enrollment: 20 (—)

## Conditions studied

- Anorexia Nervosa

## Interventions

- **DRUG:** olanzapine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00592930
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-06
- **Primary completion:** 2004-12
- **Final completion:** 2004-12
- **Target enrollment:** 20 (—)
- **Last updated:** 2008-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00592930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00592930, "Olanzapine in the Treatment of Anorexia Nervosa". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00592930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*